Heartbeam Inc. Warrant (BEATW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Heartbeam Inc. Warrant (BEATW) is down 89.8% since the beginning of the year. At $0 per share, BEATW is trading 94.2% below its 52-week high of $1.

Heartbeam Inc. Warrant (BEATW) has returned -89.81% so far this year and -91.85% over the past 12 months.

Based on dividend-adjusted daily data since Nov 11, 2021, BEATW's average daily return is +0.42%, while the average monthly return is +3.90%. At this rate, an investment would double in approximately 1.5 years.

Historically, 39% of months were positive and 61% were negative. The best month was May 2024 with a return of +275.0%, while the worst month was Nov 2025 at -64.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.

On a daily basis, BEATW closed higher 30% of trading days. The best single day was Dec 22, 2023 with a return of +75.1%, while the worst single day was Nov 21, 2025 at -59.8%.

Heartbeam Inc. Warrant has an annualized alpha of 179.46%, beta of 0.14, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 11, 2021.

• This stock participated in 144.03% of S&P 500 Index downside but only -85.22% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.14 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BEATW ranks 16 for risk / return — in the bottom 16% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Heartbeam Inc. Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Heartbeam Inc. Warrant was 97.68%, occurring on Jun 16, 2026. The portfolio has not yet recovered.

The current Heartbeam Inc. Warrant drawdown is 97.64%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Heartbeam Inc. Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Heartbeam Inc. Warrant is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.